Solventum Corporation
SOLV
$72.72
$0.340.47%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.39B | 8.31B | 8.25B | 8.22B | 8.21B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.39B | 8.31B | 8.25B | 8.22B | 8.21B |
| Cost of Revenue | 3.79B | 3.74B | 3.64B | 3.58B | 3.53B |
| Gross Profit | 4.60B | 4.56B | 4.61B | 4.63B | 4.68B |
| SG&A Expenses | 3.02B | 2.94B | 2.77B | 2.58B | 2.40B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.56B | 7.45B | 7.18B | 6.93B | 6.69B |
| Operating Income | 830.00M | 858.00M | 1.08B | 1.28B | 1.52B |
| Income Before Tax | 322.00M | 315.00M | 606.00M | 983.00M | 1.32B |
| Income Tax Expenses | -58.00M | -64.00M | 127.00M | 263.00M | 258.00M |
| Earnings from Continuing Operations | 380.00 | 379.00 | 479.00 | 720.00 | 1.06K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 380.00M | 379.00M | 479.00M | 720.00M | 1.06B |
| EBIT | 830.00M | 858.00M | 1.08B | 1.28B | 1.52B |
| EBITDA | 1.36B | 1.40B | 1.63B | 1.83B | 2.07B |
| EPS Basic | 2.19 | 2.19 | 2.77 | 4.16 | 6.12 |
| Normalized Basic EPS | 1.48 | 1.42 | 2.41 | 3.55 | 4.76 |
| EPS Diluted | 2.17 | 2.17 | 2.76 | 4.15 | 6.11 |
| Normalized Diluted EPS | 1.47 | 1.42 | 2.41 | 3.55 | 4.76 |
| Average Basic Shares Outstanding | 694.60M | 693.70M | 692.70M | 692.00M | 691.30M |
| Average Diluted Shares Outstanding | 698.40M | 696.70M | 694.60M | 692.80M | 691.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |